Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pileri

Showing results (391-400 of 524) with videos related to

Pageof 53
Sort By:
Leukemia|October 7, 2005
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphomaD Rossi, M Cerri, D Capello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meetingMaurilio Ponzoni, Andrés J M Ferreri, Elías Campo, et al.
Haematologica|March 26, 2003
Primary bone lymphoma: experience with 52 patientsPier Luigi Zinzani, Giovanna Carrillo, Stefano Ascani, et al.
Blood|July 27, 2000
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionM Magni, M Di Nicola, L Devizzi, et al.
The American Journal of Pathology|September 11, 2001
Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathyS A Pileri, F Facchetti, S Ascani, et al.
Haematologica|October 6, 1999
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapyM Boccadoro, C Tarella, A Palumbo, et al.
Haematologica|May 30, 2020
Evolutionary crossroads: morphological heterogeneity reflects divergent intra-clonal evolution in a case of high-grade B-cell lymphomaValentina Tabanelli, Federica Melle, Giovanna Motta, et al.
Experimental Hematology|February 13, 2001
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patientsM Ladetto, S Sametti, J W Donovan, et al.
Leukemia|November 14, 2008
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARFN Bolli, M F De Marco, M P Martelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cellsP Corradini, C Voena, C Tarella, et al.
Pageof 53

Showing results (391-400 of 524) with videos related to

Sort By:
Pageof 53
Leukemia|October 7, 2005
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphomaD Rossi, M Cerri, D Capello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meetingMaurilio Ponzoni, Andrés J M Ferreri, Elías Campo, et al.
Haematologica|March 26, 2003
Primary bone lymphoma: experience with 52 patientsPier Luigi Zinzani, Giovanna Carrillo, Stefano Ascani, et al.
Blood|July 27, 2000
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionM Magni, M Di Nicola, L Devizzi, et al.
The American Journal of Pathology|September 11, 2001
Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathyS A Pileri, F Facchetti, S Ascani, et al.
Haematologica|October 6, 1999
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapyM Boccadoro, C Tarella, A Palumbo, et al.
Haematologica|May 30, 2020
Evolutionary crossroads: morphological heterogeneity reflects divergent intra-clonal evolution in a case of high-grade B-cell lymphomaValentina Tabanelli, Federica Melle, Giovanna Motta, et al.
Experimental Hematology|February 13, 2001
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patientsM Ladetto, S Sametti, J W Donovan, et al.
Leukemia|November 14, 2008
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARFN Bolli, M F De Marco, M P Martelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cellsP Corradini, C Voena, C Tarella, et al.
Pageof 53